Rtw Investments, LP Mirati Therapeutics, Inc. Transaction History

Rtw Investments, LP

$5.99 Billion
Q2 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$27.8 - $45.35 $63.8 Million - $104 Million	2,295,529 Added 51.32%	6,768,514 $295 Million
Q2 2023 Aug 14, 2023	BUY	$36.13 - $49.49 $30 Million - $41.1 Million	829,871 Added 22.78%	4,472,985 $162 Million
Q4 2022 Feb 14, 2023	BUY	$41.27 - $98.62 $72.7 Million - $174 Million	1,760,451 Added 93.51%	3,643,114 $165 Million
Q2 2022 Aug 15, 2022	BUY	$39.16 - $88.71 $12.6 Million - $28.5 Million	321,166 Added 20.57%	1,882,663 $126 Million
Q4 2021 Feb 14, 2022	BUY	$132.01 - $190.29 $9.1 Million - $13.1 Million	68,965 Added 4.62%	1,561,497 $229 Million
Q3 2021 Nov 15, 2021	BUY	$132.13 - $177.45 $4.62 Million - $6.21 Million	35,000 Added 2.4%	1,492,532 $264 Million
Q2 2021 Aug 13, 2021	BUY	$144.0 - $179.73 $17.9 Million - $22.3 Million	124,300 Added 9.32%	1,457,532 $235 Million
Q1 2021 May 14, 2021	BUY	$158.92 - $221.61 $44.3 Million - $61.8 Million	278,868 Added 26.45%	1,333,232 $228 Million
Q4 2020 Feb 16, 2021	SELL	$162.05 - $240.27 $6.75 Million - $10 Million	-41,641 Reduced 3.8%	1,054,364 $232 Million
Q3 2020 Nov 16, 2020	BUY	$113.26 - $167.27 $937,679 - $1.38 Million	8,279 Added 0.76%	1,096,005 $182 Million
Q2 2020 Aug 14, 2020	BUY	$72.01 - $120.39 $7.39 Million - $12.3 Million	102,560 Added 10.41%	1,087,726 $124 Million
Q1 2020 May 15, 2020	BUY	$69.78 - $116.21 $23.7 Million - $39.5 Million	339,739 Added 52.64%	985,166 $75.7 Million
Q4 2019 Feb 14, 2020	BUY	$70.76 - $128.86 $3.73 Million - $6.78 Million	52,651 Added 8.88%	645,427 $83.2 Million
Q3 2019 Nov 14, 2019	BUY	$77.91 - $109.6 $26.3 Million - $37 Million	337,506 Added 132.22%	592,776 $46.2 Million
Q2 2019 Aug 14, 2019	SELL	$59.49 - $104.71 $3.38 Million - $5.95 Million	-56,823 Reduced 18.21%	255,270 $26.3 Million
Q1 2019 May 15, 2019	BUY	$43.65 - $78.95 $11.9 Million - $21.6 Million	273,328 Added 705.09%	312,093 $22.9 Million
Q4 2018 Feb 14, 2019	BUY	$32.0 - $47.43 $1.24 Million - $1.84 Million	38,765 New	38,765 $1.64 Million

Others Institutions Holding MRTX

# of Institutions

Shares Held

3.57M

Call Options Held

Put Options Held

36.6K

View Full List

About Mirati Therapeutics, Inc.

Ticker MRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,609,800
Description
Mirati Therapeutics, Inc., a clinical-stage oncology company, develops product candidates to address the genetic and immunological promoters of cancer in the United States. The company develops MRTX849, a KRAS G12C inhibitor, which is in Phase 1/2 clinical trial for treating non-small cell lung (NSCL), colorectal, pancreatic, and other cancers; ...

More about MRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rtw Investments, LP, based on Form 13F filings with the SEC.

News

Stay updated on Rtw Investments, LP with notifications on news.

Account